Trial reportMedical science monitor : international medical journal of experimental and clinical research2025
Epidural-Related Fever and Cesarean Delivery: Comparing Ropivacaine/Dexmedetomidine and Ropivacaine/Sufentanil: A Single-Center Randomized Controlled Study in 695 Women.
Trial report in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Epidural analgesia during labor is known to increase the risk of intrapartum hyperthermia, which can lead to higher cesarean section rates and antibiotic use due to the difficulty in distinguishing it from intrapartum infections. This study investigated the impact of 2 epidural analgesic combinations - ropivacaine/dexmedetomidine and ropivacaine/sufentanil - on the incidence of cesarean deliveries prompted by intrapartum hyperthermia. MATERIAL AND METHODS In this single-center, randomized controlled trial, 695 pregnant women were assigned to receive ropivacaine with either dexmedetomidine (Dex group, n=322) or sufentanil (control, C group, n=326) for labor epidural analgesia. We introduced the concept of 'cesarean delivery due to epidural-related fever' and evaluated the incidence of hyperthermia, overall cesarean delivery rates, and cesarean deliveries specifically due to epidural-related fever in both groups. RESULTS The Dex group exhibited a significantly lower incidence of hyperthermia compared with the C group (18.0% vs 28.5%, P=0.002). Additionally, cesarean deliveries due to epidural-related fever were notably reduced in the Dex group (0.9% vs 5.2%, P=0.02). No significant differences were observed between the groups in overall cesarean delivery rates (25.5% vs 25.2%, P=0.927), or in neonatal Apgar scores ≤7 at 1 minute (5.3% vs 5.2%, P=0.971) and 5 minutes (0.0% vs 1.2%, P=0.136). CONCLUSIONS This study is the first to identify 'cesarean delivery due to epidural-related fever' as a distinct factor influencing cesarean rates. Epidural dexmedetomidine significantly reduced the incidence of such fever, thereby decreasing the rate of cesarean deliveries attributed to it. These findings suggest a potential advantage of using dexmedetomidine in labor epidural analgesia to improve maternal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.